Ariela Noy

Cancer Center Support Grant

National Cancer Institute · P30

Project lead · $238.4K · Sloan-Kettering Inst Can Research

Clonotypic Pcr for Minimal Residual Disease in Lymphoma

National Cancer Institute · K08

Contact PI · $410.4K · Sloan-Kettering Inst Can Research

Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study

Principal investigator · Not yet recruiting · Phase 2

AIDS Malignancy Consortium

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Principal investigator · Recruiting · Phase 1

AIDS Malignancy Consortium

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Principal investigator · Recruiting · Early phase 1

AIDS Malignancy Consortium

A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma

Principal investigator · Active not recruiting · Phase 3

Memorial Sloan Kettering Cancer Center